Concepedia

Author

Katja Deterding

Medizinische Hochschule Hannover

Also Known As

Benjamin Massoumy, Deterding, K., Heiner Wedemeyer, K Deterding, K. Deterding, Katja Deterding

265

Publications

5.6K

Citations

40

H-Index

43

Concepts

All Affiliations

Medizinische Hochschule HannoverGerman Center for Infection ResearchGoethe University FrankfurtEssen University HospitalCharité - Universitätsmedizin Berlin
KD

About

Katja Deterding is an author at Medizinische Hochschule Hannover specializing in viral hepatitis, hepatitis, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

20

26

1.8K

2

Epidemiology

4

4

681

3

Public Health

1

1

12

4

Emergency Medicine

1

1

95

5

Global Health

1

1

12

Katja Deterding

×

75

Publications

5K

Citations

40

H-Index

YearCitations

Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective

Jerzy Jaroszewicz, Beatriz Calle Serrano, Karsten Wursthorn,

Journal of Hepatology

2010

399

Long-Term Efficacy of Tenofovir Monotherapy for Hepatitis B Virus-Monoinfected Patients After Failure of Nucleoside/Nucleotide Analogues

Florian van Bömmel, Robert A. de Man, Heiner Wedemeyer,

Hepatology

2009

330

Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians

P. Arends, Milan J. Sonneveld, Roeland Zoutendijk,

Gut

2014

205

Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis

Roeland Zoutendijk, Jurriën G.P. Reijnders, Fabien Zoulim,

Gut

2012

186

Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response

Roeland Zoutendijk, Jurriën G.P. Reijnders, Ashley Brown,

Hepatology

2011

171

Telomerase gene mutations are associated with cirrhosis formation

Daniel Hartmann, Ujala Srivastava, Michaela Thaler,

Hepatology

2011

170

Nonreversible MAIT cell‐dysfunction in chronic hepatitis C virus infection despite successful interferon‐free therapy

Julia Hengst, Benedikt Strunz, Katja Deterding,

European Journal of Immunology

2016

167

Direct-Acting Antiviral–Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C

Julia Hengst, Christine S. Falk, Verena Schlaphoff,

The Journal of Infectious Diseases

2016

163

Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D

Benjamin Maasoumy, Steffen B. Wiegand, Jerzy Jaroszewicz,

Clinical Microbiology and Infection

2015

141

Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B

Christoph Höner zu Siederdissen, Franziska Rinker, Benjamin Maasoumy,

The Journal of Infectious Diseases

2016

136

Page 1